Get started
Author

Marietta Nygaard

Observed names: M. Nygaard, M. Nygåard, Nygaard, Marietta
Institution: Rigshospitalet
ORCID: 0000-0002-8339-8899
Observed ORCID: 0000-0002-8339-8899
OpenAlex ID: A5053647644
COVID-19 infection in adult patients with hematological malignancies: a European Hematology Association Survey (EPICOVIDEHA)
2021 · Livio Pagano, Jon Salmanton-García, et al. · Journal of Hematology & Oncology · 316
PDF
Extracorporeal photopheresis for graft‐vs‐host disease: A literature review and treatment guidelines proposed by the Nordic ECP Quality Group
2020 · Marietta Nygaard, Stina Wichert, et al. · European Journal Of Haematology · 40
Decoding the historical tale: COVID-19 impact on haematological malignancy patients—EPICOVIDEHA insights from 2020 to 2022
2024 · Jon Salmanton-García, Francesco Marchesi, et al. · EClinicalMedicine · 35
PDF
Evaluation of infliximab as second-line treatment of acute graft versus host disease -validating response on day 7 and 28 as predictors of survival
2018 · Marietta Nygaard, Niels Smedegaard Andersen, et al. · Bone Marrow Transplantation · 15
PDF
Extracorporeal photopheresis is a valuable treatment option in steroid-refractory or steroid-dependent acute graft versus host disease—experience with three different approaches
2018 · Marietta Nygaard, Tonny Karlsmark, et al. · Bone Marrow Transplantation · 14
Longitudinal follow-up of response status and concomitant immunosuppression in patients treated with extracorporeal photopheresis for chronic graft versus host disease
2018 · Marietta Nygaard, Tonny Karlsmark, et al. · Bone Marrow Transplantation · 12
Feasibility of extracorporeal photopheresis in pediatric patients with graft‐versus‐host disease after hematopoietic stem cell transplantation
2019 · Signe Winther‐Jørgensen, Marietta Nygaard, et al. · Pediatric Transplantation · 10
Haemoglobinopathia Ypsilanti – A rare, but important differential diagnosis to polycythaemia vera
2013 · Marietta Nygaard, Jesper Petersen, et al. · Leukemia Research Reports · 8
PDF
Outpatient Management of Patients Conditioned with Fludarabine and Treosulfan prior to Allogeneic Hematopoietic Cell Transplantation
2024 · Johanne Skovgaard Schovsbo, Lars Kjeldsen, et al. · Transplantation and Cellular Therapy · 3
Oral cyclosporine A treatment is feasible after myeloablative conditioning in allogeneic hematopoietic stem cell transplantation
2015 · M. Nygaard, D. Hovgaard, et al. · Journal of Clinical Pharmacy and Therapeutics · 2
PDF
Non-myeloablative Allogeneic Hematopoietic Stem Cell Transplantation for Myelofibrosis. A Population-Based Study from Eastern Denmark
2025 · Morten Orebo Holmström, Lia Minculescu, et al. · Transplantation and Cellular Therapy · 1
Experience with the Use of Infliximab and/or Extracorporeal Photopheresis in Steroid-Refractory Acute Graft Versus Host Disease
2018 · Marietta Nygaard, Tonny Karlsmark, et al. · Transplantation and Cellular Therapy · 1
Immune reconstitution in patients with myelofibrosis conditioned with a non-myeloablative regimen prior to allogeneic stem cell transplantation
2026 · Morten Orebo Holmström, Lia Minculescu, et al. · Bone Marrow Transplantation
Outcomes After Standard- Vs. Reduced-dose Treosulfan in Allogeneic Hematopoietic Cell Transplantation
2026 · Schovsbo, Johanne, Wedge, Eileen, et al. · Research at the University of Copenhagen (University of Copenhagen)
Individualized Treosulfan-Based Conditioning Improves Outcomes of Allogeneic Hematopoietic Transplantation for Myelodysplastic Syndrome: A 25-Year Retrospective, Population-Based Analysis
2025 · Johanne Skovgaard Schovsbo, Eileen Donohue Wedge, et al. · Transplantation and Cellular Therapy
Reliability of Cyclosporine A Values Taken through Central Venous Lines - a Quality Management Study
2016 · Ann-Mari Berthelsen, Marietta Nygaard, et al. · Transplantation and Cellular Therapy
PDF
2267 Rising incidence and improved survival of squamous cell carcinoma of the anal canal in Norway 1980–2011
2015 · M. Guren, B. Aagnes, et al. · European Journal of Cancer
Close Monitoring of Cyclosporine A Concentration as a Means of Preventing Acute Graft-Versus-Host Disease in Allogeneic Stem Cell Recipients
2014 · Marietta Nygaard, Doris Hovgaard, et al. · Transplantation and Cellular Therapy
PDF
Works count: 23
Citation count: 457
H-index: 8
I10-index: 7
Year
Topic
Type